138 related articles for article (PubMed ID: 30904080)
1. Large-Giant Congenital Melanocytic Nevi: Moving Beyond NRAS Mutations.
Stark MS
J Invest Dermatol; 2019 Apr; 139(4):756-759. PubMed ID: 30904080
[TBL] [Abstract][Full Text] [Related]
2. Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations.
Martins da Silva V; Martinez-Barrios E; Tell-Martí G; Dabad M; Carrera C; Aguilera P; Brualla D; Esteve-Codina A; Vicente A; Puig S; Puig-Butillé JA; Malvehy J
J Invest Dermatol; 2019 Apr; 139(4):900-908. PubMed ID: 30359577
[TBL] [Abstract][Full Text] [Related]
3. Aggressive melanoma in an infant with congenital melanocytic nevus syndrome and multiple, NRAS and BRAF mutation-negative nodules.
de la Rosa Carrillo D; Vindenes H; Kinsler VA; Rønnestad A; Ringstad G; Müller LO; Tafjord S; Tønseth KA; Kvamme B; Clausen OPF
Pediatr Dermatol; 2018 Sep; 35(5):e281-e285. PubMed ID: 29999207
[TBL] [Abstract][Full Text] [Related]
4. BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi.
Francis JH; Grossniklaus HE; Habib LA; Marr B; Abramson DH; Busam KJ
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):117-121. PubMed ID: 29332123
[TBL] [Abstract][Full Text] [Related]
5. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
[TBL] [Abstract][Full Text] [Related]
6. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi.
Charbel C; Fontaine RH; Malouf GG; Picard A; Kadlub N; El-Murr N; How-Kit A; Su X; Coulomb-L'Hermine A; Tost J; Mourah S; Aractingi S; Guégan S
J Invest Dermatol; 2014 Apr; 134(4):1067-1074. PubMed ID: 24129063
[TBL] [Abstract][Full Text] [Related]
7. Genomic analysis of adult case of ocular surface giant congenital melanocytic nevus and associated clinicopathological findings.
McGrath LA; Palmer JM; Stark A; Glasson W; Warrier SK; Whitehead K; Hamilton H; Brooks K; Johansson PA; Hayward NK
Ophthalmic Genet; 2020 Dec; 41(6):616-620. PubMed ID: 32814477
[TBL] [Abstract][Full Text] [Related]
8. Molecular Genomic Profiling of Melanocytic Nevi.
Colebatch AJ; Ferguson P; Newell F; Kazakoff SH; Witkowski T; Dobrovic A; Johansson PA; Saw RPM; Stretch JR; McArthur GA; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Waddell N; Scolyer RA; Wilmott JS
J Invest Dermatol; 2019 Aug; 139(8):1762-1768. PubMed ID: 30772300
[TBL] [Abstract][Full Text] [Related]
9. Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi.
Gerami P; Paller AS
J Invest Dermatol; 2013 Sep; 133(9):2127-30. PubMed ID: 23949765
[TBL] [Abstract][Full Text] [Related]
10. Spatiotemporal expression of NRAS and occurrence of giant congenital melanocytic nevi.
Aimaier R; Chung M; Zhu H; Yu Q
Exp Dermatol; 2022 Apr; 31(4):582-585. PubMed ID: 35020224
[TBL] [Abstract][Full Text] [Related]
11. Naevus spilus-type congenital melanocytic naevus associated with a novel NRAS codon 61 mutation.
Krengel S; Widmer DS; Kerl K; Levesque MP; Schiestl C; Weibel L
Br J Dermatol; 2016 Mar; 174(3):642-4. PubMed ID: 26302237
[No Abstract] [Full Text] [Related]
12. Hiding in plain sight: molecular genetics applied to giant congenital melanocytic nevi.
Etchevers HC
J Invest Dermatol; 2014 Apr; 134(4):879-882. PubMed ID: 24646799
[TBL] [Abstract][Full Text] [Related]
13. Prepubertal Melanoma Arising within a Medium-Sized Congenital Melanocytic Nevus.
Lalor L; Busam K; Shah K
Pediatr Dermatol; 2016 Nov; 33(6):e372-e374. PubMed ID: 27573553
[TBL] [Abstract][Full Text] [Related]
14. Epidermal, sebaceous, and melanocytic nevoid proliferations are spectrums of mosaic RASopathies.
Luo S; Tsao H
J Invest Dermatol; 2014 Oct; 134(10):2493-2496. PubMed ID: 25219651
[TBL] [Abstract][Full Text] [Related]
15. Combination of Congenital and Deep Penetrating Nevus by Acquisition of β-Catenin Activation.
Garrido MC; Nájera L; Navarro A; Huerta V; Garrido E; Rodriguez-Peralto JL; Requena L
Am J Dermatopathol; 2020 Dec; 42(12):948-952. PubMed ID: 32568834
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of liquid biopsy for monitoring patients with NRAS-mutant medium-to-giant congenital melanocytic nevi.
Calbet-Llopart N; Tell-Martí G; Mateu J; Feito M; Martínez S; Puig S; Malvehy J; Carrera C; Puig-Butillé JA
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):e200-e203. PubMed ID: 36151998
[No Abstract] [Full Text] [Related]
17. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.
Kinsler VA; Thomas AC; Ishida M; Bulstrode NW; Loughlin S; Hing S; Chalker J; McKenzie K; Abu-Amero S; Slater O; Chanudet E; Palmer R; Morrogh D; Stanier P; Healy E; Sebire NJ; Moore GE
J Invest Dermatol; 2013 Sep; 133(9):2229-36. PubMed ID: 23392294
[TBL] [Abstract][Full Text] [Related]
18. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations.
Bauer J; Curtin JA; Pinkel D; Bastian BC
J Invest Dermatol; 2007 Jan; 127(1):179-82. PubMed ID: 16888631
[TBL] [Abstract][Full Text] [Related]
19. Congenital melanocytic nevi: update in genetics and management.
Price HN
Curr Opin Pediatr; 2016 Aug; 28(4):476-82. PubMed ID: 27307047
[TBL] [Abstract][Full Text] [Related]
20. RAF1 Gene Fusions as a Possible Driver Mechanism in Rare BAP1-Inactivated Melanocytic Tumors: A Report of 2 Cases.
Donati M; Martinek P; Kastnerova L; Persichetti P; Michal M; Kazakov DV
Am J Dermatopathol; 2020 Dec; 42(12):961-966. PubMed ID: 32769548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]